周邊血管設備市場規模、佔有率和成長分析（按類型、應用、最終用途和地區）- 產業預測 2025-2032

預計 2023 年周邊血管設備市場規模將達到 84.9 億美元，並將從 2024 年的 89.6 億美元成長到 2032 年的 137.5 億美元，預測期內（2025-2032 年）的複合年成長率為 5.5%。

由於血管疾病發病率不斷上升和人口老化，全球周邊血管設備市場正在經歷顯著成長。糖尿病和肥胖症等與文明病的增加加劇了這一趨勢，推動了對創新治療方案的需求。這些設備有助於進行血管成形術和支架置入術等微創干預，從而提高患者的舒適度並縮短恢復時間。影像技術的進步和有利的報銷政策進一步刺激了市場擴張，然而嚴格的法規和高成本等挑戰仍然存在，尤其是在新興市場。值得注意的趨勢包括藥物塗層球囊和生物可吸收支架的發展，以及對個人化醫療和數位健康解決方案的日益關注，旨在最佳化患者結果和提高治療依從性。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

周邊血管設備市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 外周支架
• PTA氣球
• 栓塞保護裝置
• 主動脈支架
• 人工外科植入物
• 慢性完全封堵裝置
• 其他

周邊血管設備市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 周邊動脈疾病(PAD)
• 動脈瘤
• 靜脈疾病

周邊血管設備市場規模（依最終用途及複合年成長率分類）（2025-2032）

• 市場概況
• 醫院
• 門診手術中心（ASC）
• 專科門診
• 其他

周邊血管設備市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic plc（USA）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Becton, Dickinson and Company（USA）
• Koninklijke Philips NV（Netherlands）
• Cook Medical Inc.（USA）
• Terumo Corporation（Japan）
• Cardinal Health, Inc.（USA）
• B. Braun Melsungen AG（Germany）
• BIOTRONIK SE & Co. KG（Germany）
• WL Gore & Associates, Inc.（USA）
• Getinge AB（Sweden）
• MicroPort Scientific Corporation（China）
• CryoLife, Inc.（USA）
• Lombard Medical（UK）
• Merit Medical Systems, Inc.（USA）
• Edwards Lifesciences Corporation（USA）
• Nipro Corporation（Japan）
• Bluesail Medical Co., Ltd.（China）

結論和建議

Peripheral Vascular Devices Market size was valued at USD 8.49 billion in 2023 and is poised to grow from USD 8.96 billion in 2024 to USD 13.75 billion by 2032, growing at a CAGR of 5.5% during the forecast period (2025-2032).

The global Peripheral Vascular Devices Market is experiencing significant growth driven by the rising incidence of vascular diseases and an aging population. Increasing lifestyle-related conditions such as diabetes and obesity contribute to this trend, boosting the demand for innovative treatment solutions. These devices facilitate minimally invasive interventions like angioplasty and stenting, which enhance patient comfort and reduce recovery times. Advancements in imaging technologies and favorable reimbursement policies further stimulate market expansion, though challenges such as stringent regulations and high costs persist, particularly in emerging markets. Notable trends include the development of drug-coated balloons and bioresorbable stents, alongside a growing emphasis on personalized medicine and digital health solutions, which aim to optimize patient outcomes and improve adherence to treatment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Vascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Vascular Devices Market Segments Analysis

Global Peripheral Vascular Devices Market is segmented by Type, Application, End-Use and region. Based on Type, the market is segmented into Peripheral Stents, PTA Balloons,embolic protection devices, Aortic Stents, Synthetic Surgical Grafts, Chronic Total Occlusion Devices and Others. Based on Application, the market is segmented into Peripheral Arterial Disease (PAD), Aneurysms and Venous Diseases. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Vascular Devices Market

The peripheral vascular devices market is significantly influenced by the escalating incidence of cardiovascular conditions, including peripheral artery disease (PAD) and deep vein thrombosis (DVT). As reported by the World Health Organization (WHO), cardiovascular diseases rank as the primary cause of mortality globally. This rising prevalence not only underscores the urgent need for effective diagnostic and treatment solutions but also fosters an expanding demand for peripheral vascular devices. The ongoing health challenges presented by these conditions are driving advancements and innovations in this market, highlighting its critical role in enhancing patient outcomes and managing cardiovascular health.

Restraints in the Peripheral Vascular Devices Market

One of the major constraints facing the peripheral vascular devices market is the substantial cost linked to these products. The expenses stem from various factors, including extensive research and development expenditures, stringent regulatory compliance, and the incorporation of advanced materials and technologies. These high price tags can hinder the widespread adoption of these devices, especially in developing nations where healthcare budgets are constrained and reimbursement systems often pose challenges. Consequently, the financial burden associated with peripheral vascular devices may restrict their accessibility and utilization, limiting the market's growth potential.

Market Trends of the Peripheral Vascular Devices Market

The peripheral vascular devices market is witnessing a significant shift towards drug-eluting devices, reflecting a heightened demand for innovations that enhance patient outcomes. These advanced devices deliver targeted therapeutic agents directly to affected blood vessels, effectively mitigating the risk of restenosis and minimizing the necessity for repeated interventions. By utilizing drug-eluting stents that disperse anti-proliferative medications, this market trend not only improves long-term efficacy for patients but also aligns with the broader healthcare focus on personalized treatment approaches. As healthcare providers prioritize strategies that optimize recovery and reduce healthcare costs, the adoption of drug-eluting technologies is expected to accelerate in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Peripheral Vascular Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Peripheral Stents
• PTA Balloons
• Embolic Protection Devices
• Aortic Stents
• Synthetic Surgical Grafts
• Chronic Total Occlusion Devices
• Others

Global Peripheral Vascular Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Peripheral Arterial Disease (PAD)
• Aneurysms
• Venous Diseases

Global Peripheral Vascular Devices Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

Global Peripheral Vascular Devices Market Size & CAGR (2025-2032)

• North America (Type, Application, End-Use)
  • US
  • Canada
• Europe (Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bluesail Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations